跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,102 条关于
“CGI-S”
全部
11,102
临床试验
4,294
药物
2,176
机构
257
资讯
4,375
去年
Xanomeline-Trospium Shows Consistent Efficacy in Schizophrenia Across Pooled Phase 3 Trials
去年
Olanzapine and Samidorphan Combination Shows Sustained Schizophrenia Symptom Control in Long-Term Study
去年
Cobenfy Demonstrates Sustained Efficacy in Long-Term Schizophrenia Treatment
去年
Cobenfy Shows Sustained Efficacy and Safety in Long-Term Schizophrenia Trials
去年
Rafael Holdings Reports 78% Success Rate for NPC1 Treatment in Phase 3 Pediatric Sub-Study
3天前
Definium Therapeutics to Report Phase 3 Panorama Topline Results for LSD-Based Anxiety Drug DT120
去年
Neurocrine Biosciences Advances Novel Muscarinic M4 Agonist to Phase 3 Trials for Schizophrenia
去年
CBD Shows Promise in Treating Neuropsychiatric Disorders in Tuberous Sclerosis Complex
2年前
Phase IIb Trial Evaluates Efficacy and Safety of Anyu Peibo Capsules for Major Depressive Disorder
2年前
Neurocrine's NBI-1117568 Shows Promise in Phase II Schizophrenia Trial
第 1 页,共 438 页
上一页
下一页